MOD GRF1-29 (CJC-1295 no DAC) 5mg
Is a synthetic analog of the endogenous Growth Hormone Releasing Hormone (GHRH), designed to stimulate the release of growth hormone (GH) by increasing the binding affinity to GHRH receptors. Modified GRF 1-29, also known as CJC-1295 without DAC, contains a modified amino acid sequence that enhances its stability, prolongs its half-life, and boosts its effectiveness in stimulating GH secretion.
Key Benefits of MOD GRF 1-29 (CJC-1295 no DAC):
Enhanced Growth Hormone Secretion:
By mimicking the action of natural GHRH, Modified GRF 1-29 effectively stimulates the pituitary gland to release growth hormone, supporting muscle growth, fat metabolism, and overall vitality.Increased Binding Affinity for GHRH Receptors:
The modifications to the peptide chain increase its binding affinity to the GHRH receptors, leading to a more efficient release of growth hormone and greater effectiveness compared to natural GHRH.Improved Muscle Mass and Strength:
With enhanced GH release, MOD GRF 1-29 promotes anabolic effects, stimulating protein synthesis and aiding in the development of lean muscle mass, which is essential for strength gains and athletic performance.Fat Loss and Improved Body Composition:
Increased growth hormone levels lead to enhanced lipolysis, which supports fat breakdown and improved body composition. As a result, users may experience a reduction in body fat while preserving or increasing muscle mass.Faster Recovery and Regeneration:
Growth hormone plays a crucial role in tissue repair and regeneration. MOD GRF 1-29 accelerates recovery times, reduces muscle soreness, and promotes the healing of damaged tissues, making it beneficial for athletes and individuals recovering from intense physical exertion or injury.Sustained and Long-Lasting Effects:
Unlike other GHRH analogs, MOD GRF 1-29 (CJC-1295 no DAC) has been designed to prevent degradation and oxidation, offering prolonged effects and a more stable release of GH, ensuring greater consistency in its benefits over time.Improved Sleep Quality:
Increased GH secretion has been shown to enhance sleep quality by regulating circadian rhythms, contributing to deeper and more restorative sleep, which is essential for recovery and overall well-being.
Conclusion:
MOD GRF 1-29 (CJC-1295 no DAC) 5mg is a highly effective peptide for boosting growth hormone release, promoting muscle growth, fat loss, faster recovery, and improved sleep. Its stability, extended half-life, and increased receptor affinity make it a superior choice for individuals seeking to optimize their growth hormone levels naturally and safely.
MOD GRF1-29 (CJC-1295 no DAC) 5mg
Modified GRF (1-29), CJC-1295 no DAC
Modified Growth Releasing Factor aminos 1-29, usually referred to as Modified GRF (1-29) or “ModGRF(1-29),” also known as CJC-1295 without DAC, is a synthetic analog of the endogenous peptide signaling hormone Growth Hormone Releasing Hormone (GHRH). Endogenously produced GHRH has 44 amino acids in its chain structure. A truncated synthetic form of GHRH called Sermorelin or GRF 1-29 has 29 amino acids; Modified GRF (1-29) is further changed in that it has four substituted aminos in its chain that serve the purposes of preventing degradation and oxidation in manufacture and transport as well as in vivo, while also increasing binding affinity to the GHRH receptors.
Modified GRF (1-29) is not CJC-1293 nor should it be referred to as such. Modified GRF (1-29) is identical to the portion of CJC-1295 DAC that is not bound to MPA, minus the lysine. The presence of lysine in a literal “CJC without DAC” in the absence of MPA would have the opposite effect of DAC: it would drastically reduce the active life of the peptide to that of Sermorelin. Modified GRF (1-29) is the same as CJC-1295 with out DAC.Tetrasubstitued GRF (1-29)
Modified GRF (1-29) is a synthetic modification of growth hormone releasing factor (GRF) with D-Ala, Gln, Ala, and Leu substitutions at positions 2, 8, 15, and 27 respectively. These substitutions create a much more stable peptide with the substitution at position 2 to prevent DPP-IV cleavage, position 8 to reduce asparagine rearrangement or amide hydrolysis to aspartic acid, position 15 to enhance bioactivity, and position 27 to prevent methionine oxidation.
CJC-1295 DAC vs. CJC-1295 No DAC
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Growth Hormone Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human Growth Hormone.